The biodefense market is estimated to be valued at US$ 13.4 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The biodefense market consists of countermeasures such as vaccines, drugs, and diagnostic tools used to detect and treat diseases caused by biological weapons or bioterrorism agents. Some key products in ... Read more
